Heung Tae Kim

First-SIGNAL: First-Line Single-Agent Iressa Versus Gemcitabine and Cisplatin Trial in Never-Smokers With Adenocarcinoma of the Lung

Ji‐Youn Han, Keunchil Park, Sang‐We Kim et al. · Journal of Clinical Oncology · 2012 · 735 citations

Medicine, Oncology, Pharmacology +11

Efficacy and Safety of Pembrolizumab for Heavily Pretreated Patients With Advanced, Metastatic Adenocarcinoma or Squamous Cell Carcinoma of the Esophagus

Manish A. Shah, Takashi Kojima, Daniel Hochhauser et al. · JAMA Oncology · 2018 · 519 citations · Full text

Medicine, Oncology, Pharmacology +17

A phase III randomized study of 5-fluorouracil and cisplatin versus 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil alone in the treatment of advanced gastric cancer

Noe Kyeong Kim, Young Suk Park, Dae Seog Heo et al. · Cancer · 1993 · 359 citations · Full text

Medicine, Oncology, Pharmacology +10

Associations of <i>ABCB1, ABCC2</i>, and <i>ABCG2</i> polymorphisms with irinotecan‐pharmacokinetics and clinical outcome in patients with advanced non‐small cell lung cancer

Ji‐Youn Han, Hyeong‐Seok Lim, Yeon‐Kyeong Yoo et al. · Cancer · 2007 · 197 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +16

Fibroblasts from chronic wounds show altered TGF‐β‐signaling and decreased TGF‐β Type II Receptor expression

Byung‐Chul Kim, Heung Tae Kim, Seok Hee Park et al. · Journal of Cellular Physiology · 2003 · 189 citations · Full text

Life Sciences, Cell Biology, Pathology +11